PYY and obesity disorder: Alongside the well-established anti-diabetic and lipid-lowering properties, preclinical studies also suggest that glucans may exert anti-obesity effects by activating the gut-hypothalamic (Peptide YY- Neuropetide Y) axis, therefore increasing satiety in diet-induced obese mice [81].